Zobrazeno 1 - 10
of 12
pro vyhledávání: '"José Luis Fuster-Soler"'
Autor:
Alba Ferrández-Pujante, Amparo Pérez-Silva, Clara Serna-Muñoz, José Luis Fuster-Soler, Ana Mª Galera-Miñarro, Inmaculada Cabello, Antonio J. Ortiz-Ruiz
Publikováno v:
Children, Vol 9, Iss 4, p 566 (2022)
Cancers have a highly negative impact on the quality of life of paediatric patients and require an individualised oral treatment program for the phases of the disease. The aim of this study was to update existing research on oral care in children dia
Externí odkaz:
https://doaj.org/article/16dd2fa6f2cd4706949fdb1bf5752594
Autor:
Salvador Chulián, Bernadette J Stolz, Álvaro Martínez-Rubio, Cristina Blázquez Goñi, Juan F Rodríguez Gutiérrez, Teresa Caballero Velázquez, Águeda Molinos Quintana, Manuel Ramírez Orellana, Ana Castillo Robleda, José Luis Fuster Soler, Alfredo Minguela Puras, María V Martínez Sánchez, María Rosa, Víctor M Pérez-García, Helen M Byrne
Publikováno v:
PLoS Computational Biology, Vol 19, Iss 8, p e1011329 (2023)
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates, approximately 15-20% of patients relapse. Risk of relapse is routinely estimated at diagnosis by biological factors, including flow cytometry data. T
Externí odkaz:
https://doaj.org/article/98c5115ec1784f58bba7bc06fea347cf
Autor:
Salvador Chulián, Bernadette J. Stolz, Álvaro Martínez-Rubio, Cristina Blázquez Goñi, Juan F. Rodríguez Gutiérrez, Teresa Caballero Velázquez, Águeda Molinos Quintana, Manuel Ramírez Orellana, Ana Castillo Robleda, José Luis Fuster Soler, Alfredo Minguela Puras, María V. Martínez Sánchez, María Rosa, Víctor M. Pérez-García, Helen M. Byrne
Although children and adolescents with acute lymphoblastic leukaemia (ALL) have high survival rates, approximately 15-20% of patients relapse. Risk of relapse is routinely estimated at diagnosis by biological factors, including flow cytometry data. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c434b3e6a5fdb36471b723e11061be64
https://doi.org/10.1101/2021.12.22.21268233
https://doi.org/10.1101/2021.12.22.21268233
Autor:
Lucía Fernández, Alfonso Navarro, Adrián Fernández, Antonia Pascual Martínez, Luisa Sisinni, Victor Galán, Cristina Ferreras, Jose M. Vagace Valero, Alejandra Leivas, Antonio Balas, Berta González, María Elena Vela, Adela Escudero, Dolores Corral, Lara Maria Gómez García, Jose L. Vicario, Antonio Pérez-Martínez, Paula Valle, Carmen Mestre, Isabel Mirones, Alberto M. Borobia, José Luis Fuster Soler, Raquel de Paz, Beatriz Ruz, Joaquin Martinez-Lopez, Miguel Blanquer
Publikováno v:
Clinical lymphoma, myelomaleukemia. 21(5)
Background Acute myeloid leukemia (AML) accounts for approximately 20% of pediatric leukemia cases; 30% of these patients experience relapse. The antileukemia properties of natural killer (NK) cells and their safety profile have been reported in AML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b38fc0790747ba5f090a91380f194d
https://pubmed.ncbi.nlm.nih.gov/33610500
https://pubmed.ncbi.nlm.nih.gov/33610500
Autor:
Jose L. Vicario, Adrián Fernández, José Luis Fuster Soler, Victor Galán, Antonio Pérez-Martínez, Paula Valle, Berta González, Beatriz Ruz, Cristina Ferreras, Lucía Fernández, Antonia Pascual, Isabel Mirones, Jose M. Vagace Valero, Alejandra Leivas, Alfonso Navarro Zapata, Lara Maria Gómez-García, Dolores Corral, Carmen Maestre, Raquel de Paz, Luisa Sisinni, Alberto M. Borobia, Miguel Blanquer Blanquer, Antonio Balas, Joaquin Martinez-Lopez, Adela Escudero, María Vela
Background. Acute myeloid leukemia (AML) accounts for approximately 25% of pediatric leukemia. The long term overall survival rate now approaches 70%, but up 30% relapse. The anti-leukemia properties of Natural Killer (NK) cells and its safety profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c16003b71ba803235a7e21a878e8ae4b
https://doi.org/10.22541/au.160192968.85891275/v1
https://doi.org/10.22541/au.160192968.85891275/v1
Autor:
Nerea Domínguez-Pinilla, Maria del Carmen Mendoza Sanchez, Susana Riesco, Marta Baragaño, Ana Carboné, Anna Faura Morros, Antonio Martinez, L Moreno, Jorge Huerta Aragonés, A. Lassaletta, Isabel Badell, Susana Rives Solà, Elena Sebastián, Pablo Velasco, Itziar Astigarraga, Carmen Rodriguez-Vigil, Marina García-Morín, Vanesa Pérez-Alonso, Andres Morales La Madrid, Ana Fernández-Teijeiro, Montserrat Torrent, Elena Garcia Macias, L Madero, Maria Trabazo, Luisa Sisinni, Maite Gorostegui, Sara Perez-Jaume, Luis Gros, Manuel Fernández Sanmartin, Antonio Juan Ribelles, José Luis Fuster Soler, José Luis Dapena
Publikováno v:
PEDIATRIC BLOOD & CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Background: Since the beginning of SARS-CoV-2 pandemic, it has been widely recognized that children and adolescents seem to have milder clinical courses as compared to adult counterparts. However, there is concern that vulnerable collectives includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2249a80caf3279dc3ef6207b8a6d4581
https://hdl.handle.net/10668/15943
https://hdl.handle.net/10668/15943
Autor:
Itziar Astigarraga, José Luis Fuster Soler, Miguel Blanquer Blanquer, Lucía Fernández Casanova, Berta González Martínez, Isabel Mirones Aguilar, Alberto M. Borobia, María Vela Cuenca, Mario Muñoz Builes, Jose M. Vagace Valero, Hoi Y. Tong, Jaime Valentín Quiroga, Antonio Pérez-Martínez, Luisa Sisinni, Antonia Pascual Martínez, Adela Escudero López
Publikováno v:
BMJ Open
IntroductionAcute myeloblastic leukaemia (AML) constitutes the second most common haematological malignancy in the paediatric population. Current treatment regimens are based on the administration of polychemotherapy, combining high doses of cytarabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bff96ec9d7ed7e8338324deae0b54d8
https://pubmed.ncbi.nlm.nih.gov/31919123
https://pubmed.ncbi.nlm.nih.gov/31919123
Autor:
Rosa Cabello-Laureano, Darío García-Calderon, Ramón Ruiz-Pruneda, Óscar Girón-Vallejo, José Luis Fuster-Soler, José I. Ruiz-Jiménez, Ernesto Doménech-Abellán
Publikováno v:
Pediatric bloodcancer. 65(4)
Nephron sparing surgery (NSS) is increasingly utilized to treat patients with bilateral Wilms tumor. We present a case of NSS planning using a three-dimensional computerized and printed model of both kidneys with anatomical structures of interest (pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9bbc7d539b2f4f9621cbe975703957a
https://pubmed.ncbi.nlm.nih.gov/29230948
https://pubmed.ncbi.nlm.nih.gov/29230948
Autor:
Mar Bermúdez-Cortés, Ana M. Galera-Miñarro, Esther Llinares-Riestra, Ernesto Doménech-Abellán, José Luis Fuster-Soler, Agueda Bas-Bernal, Ana María Fita
Publikováno v:
Pediatric bloodcancer. 64(8)
Pleuropulmonary blastoma (PPB) is a rare malignancy of childhood. It often represents a manifestation of a hereditary tumor predisposition syndrome (DICER1 syndrome). Because of its malignant potential, surgical resection of cystic lung lesions is re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::732ebafa5f3fa5dfbb6055e1a4c952ee
https://pubmed.ncbi.nlm.nih.gov/28097783
https://pubmed.ncbi.nlm.nih.gov/28097783
Autor:
Guadalupe Ruíz Merino, M. Amelia De la Rubia Nieto, Alberto Espuny Miró, M. Sacramento Díaz Carrasco, José Luis Fuster Soler, M. Angeles Fernández de Palencia Espinosa
Publikováno v:
International journal of clinical pharmacy. 36(6)
Background Onco-hematological patients are particularly susceptible to drug–drug interactions (DDIs) because they often undergo multiple combined treatments. Some studies have analyzed the frequency of DDIs in adult patients with cancer; however, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d8f5a9b1b26e1c3c12bfaa2513b8f0
https://pubmed.ncbi.nlm.nih.gov/25204258
https://pubmed.ncbi.nlm.nih.gov/25204258